<?xml version='1.0' encoding='utf-8'?>
<document id="27218144"><sentence text="Multiple effects of magnesium isoglycyrrhizinate on the disposition of docetaxel in docetaxel-induced liver injury."><entity charOffset="20-48" id="DDI-PubMed.27218144.s1.e0" text="magnesium isoglycyrrhizinate" /><entity charOffset="71-80" id="DDI-PubMed.27218144.s1.e1" text="docetaxel" /><entity charOffset="84-93" id="DDI-PubMed.27218144.s1.e2" text="docetaxel" /><pair ddi="false" e1="DDI-PubMed.27218144.s1.e0" e2="DDI-PubMed.27218144.s1.e0" /><pair ddi="false" e1="DDI-PubMed.27218144.s1.e0" e2="DDI-PubMed.27218144.s1.e1" /><pair ddi="false" e1="DDI-PubMed.27218144.s1.e0" e2="DDI-PubMed.27218144.s1.e2" /><pair ddi="false" e1="DDI-PubMed.27218144.s1.e1" e2="DDI-PubMed.27218144.s1.e1" /><pair ddi="false" e1="DDI-PubMed.27218144.s1.e1" e2="DDI-PubMed.27218144.s1.e2" /></sentence><sentence text="1" /><sentence text=" Magnesium isoglycyrrhizinate (MgIg) has been extensively used in treating liver injury which is the common adverse reaction of docetaxel (DOC)"><entity charOffset="128-137" id="DDI-PubMed.27218144.s3.e0" text="docetaxel" /><entity charOffset="139-142" id="DDI-PubMed.27218144.s3.e1" text="DOC" /><pair ddi="false" e1="DDI-PubMed.27218144.s3.e0" e2="DDI-PubMed.27218144.s3.e0" /><pair ddi="false" e1="DDI-PubMed.27218144.s3.e0" e2="DDI-PubMed.27218144.s3.e1" /></sentence><sentence text=" Due to the narrow therapeutic window, small changes in pharmacokinetic profiles can alter the toxicity and therapeutic efficacy of DOC significantly"><entity charOffset="132-134" id="DDI-PubMed.27218144.s4.e0" text="DOC" /></sentence><sentence text=" The study aimed to explore the effects of MgIg on the disposition of DOC and the potential mechanism in DOC-induced liver injury"><entity charOffset="70-72" id="DDI-PubMed.27218144.s5.e0" text="DOC" /><entity charOffset="105-107" id="DDI-PubMed.27218144.s5.e1" text="DOC" /><pair ddi="false" e1="DDI-PubMed.27218144.s5.e0" e2="DDI-PubMed.27218144.s5.e0" /><pair ddi="false" e1="DDI-PubMed.27218144.s5.e0" e2="DDI-PubMed.27218144.s5.e1" /></sentence><sentence text=" 2" /><sentence text=" Pharmacokinetics and tissues distribution behaviors showed that there was no significant difference between DOC group (DOCG) and MgIg + DOC group (MDOCG)"><entity charOffset="130-140" id="DDI-PubMed.27218144.s7.e0" text="MgIg + DOC" /><entity charOffset="109-118" id="DDI-PubMed.27218144.s7.e1" text="DOC" /><entity charOffset="120-129" id="DDI-PubMed.27218144.s7.e2" text="DOC" /><entity charOffset="137-146" id="DDI-PubMed.27218144.s7.e3" text="DOC" /><entity charOffset="149-158" id="DDI-PubMed.27218144.s7.e4" text="DOC" /><pair ddi="false" e1="DDI-PubMed.27218144.s7.e1" e2="DDI-PubMed.27218144.s7.e1" /><pair ddi="false" e1="DDI-PubMed.27218144.s7.e1" e2="DDI-PubMed.27218144.s7.e2" /><pair ddi="false" e1="DDI-PubMed.27218144.s7.e1" e2="DDI-PubMed.27218144.s7.e0" /><pair ddi="false" e1="DDI-PubMed.27218144.s7.e1" e2="DDI-PubMed.27218144.s7.e3" /><pair ddi="false" e1="DDI-PubMed.27218144.s7.e1" e2="DDI-PubMed.27218144.s7.e4" /><pair ddi="false" e1="DDI-PubMed.27218144.s7.e2" e2="DDI-PubMed.27218144.s7.e2" /><pair ddi="false" e1="DDI-PubMed.27218144.s7.e2" e2="DDI-PubMed.27218144.s7.e0" /><pair ddi="false" e1="DDI-PubMed.27218144.s7.e2" e2="DDI-PubMed.27218144.s7.e3" /><pair ddi="false" e1="DDI-PubMed.27218144.s7.e2" e2="DDI-PubMed.27218144.s7.e4" /><pair ddi="false" e1="DDI-PubMed.27218144.s7.e0" e2="DDI-PubMed.27218144.s7.e0" /><pair ddi="false" e1="DDI-PubMed.27218144.s7.e0" e2="DDI-PubMed.27218144.s7.e3" /><pair ddi="false" e1="DDI-PubMed.27218144.s7.e0" e2="DDI-PubMed.27218144.s7.e4" /><pair ddi="false" e1="DDI-PubMed.27218144.s7.e3" e2="DDI-PubMed.27218144.s7.e3" /><pair ddi="false" e1="DDI-PubMed.27218144.s7.e3" e2="DDI-PubMed.27218144.s7.e4" /></sentence><sentence text=" The mRNA and protein levels of cytochrome P450 3A1 (CYP3A1) in liver, intestine, and kidney were significantly upregulated, and the P-glycoprotein (P-gp) was obviously downregulated in MDOCG when compared with DOCG"><entity charOffset="187-189" id="DDI-PubMed.27218144.s8.e0" text="DOC" /><entity charOffset="211-213" id="DDI-PubMed.27218144.s8.e1" text="DOC" /><pair ddi="false" e1="DDI-PubMed.27218144.s8.e0" e2="DDI-PubMed.27218144.s8.e0" /><pair ddi="false" e1="DDI-PubMed.27218144.s8.e0" e2="DDI-PubMed.27218144.s8.e1" /></sentence><sentence text=" 3" /><sentence text=" Immunoglobulin M (IgM), CD8+ were upregulated in DOCG; while in MDOCG, IgM, CD8+ recovered to normal levels and complement C3; CD4+  were upregulated"><entity charOffset="50-52" id="DDI-PubMed.27218144.s10.e0" text="DOC" /><entity charOffset="66-68" id="DDI-PubMed.27218144.s10.e1" text="DOC" /><pair ddi="false" e1="DDI-PubMed.27218144.s10.e0" e2="DDI-PubMed.27218144.s10.e0" /><pair ddi="false" e1="DDI-PubMed.27218144.s10.e0" e2="DDI-PubMed.27218144.s10.e1" /></sentence><sentence text=" 4" /><sentence text=" MgIg had no significant effects on the disposition of DOC in docetaxel-induced liver injury"><entity charOffset="62-71" id="DDI-PubMed.27218144.s12.e0" text="docetaxel" /><entity charOffset="55-63" id="DDI-PubMed.27218144.s12.e1" text="DOC" /><pair ddi="false" e1="DDI-PubMed.27218144.s12.e1" e2="DDI-PubMed.27218144.s12.e1" /><pair ddi="false" e1="DDI-PubMed.27218144.s12.e1" e2="DDI-PubMed.27218144.s12.e0" /></sentence><sentence text=" Additional, potential drug-drug interaction may happen if MgIg co-administered with antitumor drugs which are the substrates of CYP3A4 or P-gp" /><sentence text=" Hepatoprotective mechanism of MgIg perhaps was through upregulation of C3, CD4+ and downregulation of IgM, CD8+" /><sentence text="" /></document>